Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Regulatory News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

RULE 2.10 UPDATE

4 Nov 2015 18:28

RNS Number : 6200E
Plethora Solutions Holdings PLC
04 November 2015
 

Plethora Solutions Holdings PLC

("Plethora" or the "Company")

4 November 2015

RULE 2.10 UPDATE

In accordance with 2.10 of the City Code on Takeovers and Mergers (the "Code), the Company confirms that as at the date of this announcement, it has 823,297,686 ordinary shares of £0.01 each in issue with ISIN GB00B06GL868. Plethora's ordinary shares are listed on the Alternative Investment Market of the London Stock Exchange ("AIM").

In addition, Plethora has a number of warrants, convertible loans and options/share awards outstanding (none of which have an associated ISIN number). Details of these securities are included below.

Mellon Bridge Loans: a convertible loan note due to be repaid on 31 March 2010. Upon redemption, the loan may be converted to 17,000,000 ordinary shares of 1p at an exercise price of 2p per share.

Galloway loan warrant instrument: a warrant granted to Galloway Limited to subscribe for ordinary shares of 1p representing up to 5% of the fully diluted ordinary share capital (post exercise) at a price of 1.25p per share. The warrant is due to expire on 31 March 2023 and can be exercised at any point up to this date at the discretion of Galloway. Based on the current fully diluted ordinary share capital, the warrant allows Galloway to subscribe for up to 54,118,431 shares.

CfE loan warrant instrument: a warrant granted to the Capital for Enterprise fund to subscribe for ordinary shares of 1p representing up to 3% of the fully diluted ordinary share capital (post exercise) at a price of 1p per share. The warrant is due to expire on 31 March 2023 and can be exercised at any point up to this date at the discretion of Capital for Enterprise. Based on the current fully diluted ordinary share capital, the warrant allows Capital for Enterprise to subscribe for up to 32,471,058 shares.

Fundraising Warrants: warrants attached to the capital fundraising undertaken in September 2014. Up to 101,148,981 ordinary shares of 1p may be subscribed at an exercise price of 15p.

LTIPs: share awards under the Company's Long Term Incentive Plan. A total of 54,200,000 ordinary shares of 1p each will be awarded at no subscription cost to employees based on various commercial milestones. Additionally the LTIPs will automatically vest on a change of control of Plethora.

Executive Share Option Scheme (ESOP): available to all employees and directors of the Company. A total of 132,460 ordinary shares of 1p each may be issued in relation to the scheme at a subscription price of 59p per share.

 

Romero Tayong

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RTTLLFFTLRLSIIE
Date   Source Headline
17th Nov 20107:00 amRNSChange of Adviser
10th Nov 20102:27 pmRNSHolding in Company
7th Sep 20107:00 amRNSHalf Yearly Report
29th Jul 20102:27 pmRNSHolding(s) in Company
23rd Jul 201010:55 amRNSHolding(s) in Company
19th Jul 20107:00 amRNSNew Product Launch
13th Jul 20107:00 amRNSPre-close Trading Update
30th Jun 20107:00 amRNSTerm Loan Agreement
10th Jun 201012:06 pmRNSLTIP Awards
2nd Jun 20107:00 amRNSAmerican Urological Association Showcase
27th May 20109:27 amRNSResult of AGM
17th May 20107:00 amRNSCommercial Update - The Urology Company
6th May 20107:00 amRNSAnnual Report and Accounts
5th May 20107:00 amRNSIssue of Equity
12th Apr 20107:00 amRNSExclusive Distribution Agreement
9th Mar 20107:00 amRNSPreliminary Results
24th Feb 20103:31 pmRNSHolding(s) in Company
23rd Feb 20107:00 amRNSNotice of Results
19th Jan 20107:00 amRNSPre-Close Trading Update
14th Dec 20095:23 pmRNSHolding(s) in Company
7th Dec 200911:23 amRNSResult of EGM
30th Nov 20097:00 amRNSExclusive License and Distribution Agreement
23rd Nov 20097:00 amRNSExclusive License and Distribution Agreement
19th Nov 20094:23 pmRNSDirector/PDMR Shareholding
18th Nov 20097:23 amRNSPlacing and Convertible Loan Note
30th Sep 20097:00 amRNSClinical Update re: PSD506
17th Sep 20097:00 amRNSInterim Results
7th Aug 20094:42 pmRNSHolding(s) in Company
5th Aug 200910:42 amRNSHolding(s) in Company
29th Jul 20097:00 amRNSFinal Phase III Pivotal Trial Results PSD502
16th Jul 20097:00 amRNSPSD503 Update - Evaluation and Option Agreement
25th Jun 20091:57 pmRNSAGM Statement and Trading Update
15th Jun 20093:57 pmRNSHolding(s) in Company
29th May 20093:34 pmRNSAnnual Report and Accounts and AGM Notice
26th May 20097:05 amRNSDirectorate Change
26th May 20097:00 amRNSGlobal Agreement, Restructuring and Final Results
1st Apr 20097:00 amRNSUpdate re: PSD502
19th Feb 20097:00 amRNSDirectorate Change
18th Feb 20099:24 amRNSClinical Update PSD502
16th Feb 200911:31 amRNSLoan Agreement and US License Amendment
16th Feb 200911:26 amRNSResult of General Meeting
22nd Jan 20097:00 amRNSFunding Update and Notice of GM
23rd Dec 20084:17 pmRNSHolding(s) in Company
18th Dec 200811:55 amRNSHolding(s) in Company
11th Dec 20089:12 amRNSHolding(s) in Company
8th Dec 20087:00 amRNSIssue of Equity
8th Dec 20087:00 amRNSClinical Update: PSD502
14th Nov 20087:00 amRNSHolding(s) in Company
14th Nov 20087:00 amRNSErecAid Study Results
7th Nov 20087:00 amRNSPhase III European Clinical Trial Results PSD502

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.